Accessibility Menu
 
Biomea Fusion logo

Biomea Fusion

(NASDAQ) BMEA

Current Price$1.85
Market Cap$133.75M
Since IPO (2021)-90%
5 YearN/A
1 Year+1%
1 Month+26%

Biomea Fusion Financials at a Glance

Market Cap

$133.75M

Revenue (TTM)

$0.00

Net Income (TTM)

$61.80M

EPS (TTM)

$-1.52

P/E Ratio

-1.22

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.85

Volume

134,086

Open

$1.76

Previous Close

$1.85

Daily Range

$1.68 - $1.91

52-Week Range

$0.87 - $3.08

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biomea Fusion

Industry

Biotechnology

Employees

41

CEO

Michael J. M. Hitchcock, PhD

Headquarters

Redwood City, CA 94063, US

BMEA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-152%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-81.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$133.75M

Shares Outstanding

72.30M

Volume

134.09K

Short Interest

0.00%

Avg. Volume

1.40M

Financials (TTM)

Gross Profit

$1.41M

Operating Income

$81.31M

EBITDA

$79.90M

Operating Cash Flow

$70.37M

Capital Expenditure

$0.00

Free Cash Flow

$70.37M

Cash & ST Invst.

$55.81M

Total Debt

$1.59M

Biomea Fusion Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$47.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$133.75M

N/A

Market Cap/Employee

$1.69M

N/A

Employees

79

N/A

Net Income

$4.61M

+115.7%

EBITDA

$11.67M

+60.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$54.22M

+9.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$128.00K

-98.1%

Short Term Debt

$1.46M

-29.7%

Return on Assets

-1.06%

N/A

Return on Invested Capital

-1.76%

N/A

Free Cash Flow

$13.19M

+56.2%

Operating Cash Flow

$13.19M

+56.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMUXImmunic, Inc.
$1.29+8.40%
UNCYUnicycive Therapeutics, Inc.
$6.65+3.10%
RPTXRepare Therapeutics Inc.
$2.65+0.00%
ADVMAdverum Biotechnologies, Inc.
$4.36+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
NOKNokia
$9.55+0.01%
PLTRPalantir Technologies
$130.49-0.07%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.78-0.02%

Questions About BMEA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.